Putnam Investments’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Putnam Investments’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-95,613	Closed	-$5.11M	–	1487
2016 Q1	$5.11M	Buy	95,613 +304	+0.3%	+$22.4K	0.01%	621
2015 Q4	$10.8M	Buy	95,309 +7,040	+8%	+$776K	0.02%	439
2015 Q3	$10.4M	Buy	88,269 +7,369	+9%	+$962K	0.02%	439
2015 Q2	$6.26M	Hold	80,900	–	–	0.01%	638
2015 Q1	$4.68M	Hold	80,900	–	–	0.01%	802
2014 Q4	$2.61M	Hold	80,900	–	–	0.01%	953
2014 Q3	$1.98M	Sell	80,900 -10,800	-12%	-$219K	﹤0.01%	1024
2014 Q2	$1.63M	Buy	91,700 +10,800	+13%	+$174K	﹤0.01%	1082
2014 Q1	$1.62M	Buy	+80,900	New	+$1.57M	﹤0.01%	1096

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Putnam Investments's ANAC Position: Q2 2016 in Review

Putnam Investments sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 95,613 shares — an estimated $5.11M sold.

Putnam Investments first reported a position in ANAC in Q1 2014 and held it in 9 quarters. The position peaked at $10.8M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Putnam Investments reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Putnam Investments sold 95,613 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $5.11M.
Putnam Investments first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 9 quarters.
Putnam Investments's ANACOR PHARMACEUTICALS INC COM position peaked at $10.8M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Putnam Investments's 13F filing for Q2 2016, filed 15 Aug 2016.